Preventive medicine sales will expand through 2036, with screening and early detection services holding 34.7% of the service type segment in 2026. Cardiovascular diseases prevention leads the application segment with a 31.5% share. The market is projected to reach USD 461.8 billion in 2026 and USD 766.7 billion by 2036.